AC Immune SA Follow Verify

www.acimmune.com
AC Immune SA
Type	Public
Industry	Biotechnology
Founded	2003
Headquarters	Lausanne, Switzerland
Key people	Andrea Pfeifer (Co-Founder & CEO), Jean-Fabien Monin (CFO), Andreas Muhs (CSO)
Investors	Dietmar Hopp
Number of employees	62

AC Immune SA, a clinical stage Swiss-based biopharmaceutical company, focuses on neurodegenerative diseases with three product candidates in clinical trials. It designs, discovers, and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. The company’s technology platforms create antibodies, small molecules, and vaccines to address a broad spectrum of neurodegenerative indications. It offers its therapies to address Alzheimer disease and neurodegenerative diseases, such as Parkinson’s, Down syndrome, and glaucoma.
AC Immune SA was founded in 2003 and is based in Lausanne, Switzerland.

Top 5 Recent Tweets

Date	Author	Comment
February 07, 2023	AC_Immune_SA	We are pleased to announce two new grants, one from the Michael J. Fox Foundation for Parkinson’s Research and one… https://t.co/fRgdXfkUDU
February 03, 2023	AlzheimerEurope	.@AC_Immune_SA announced initial interim safety and immunogenicity data from its ABATE Phase 1b/2 #clinicaltrial of… https://t.co/BqE2Ig810H
February 02, 2023	AC_Immune_SA	Join AC Immune’s CEO Dr. Andrea Pfeifer, on February 14th, for a Fireside chat at the SVB Securities Global Biophar… https://t.co/cIa2frTQRU
January 30, 2023	fundamentalsbot	AC Immune SA's quarterly revenue growth rate YoY of -11.10% ranked 3475 out of 5735 companies in our database.… https://t.co/ypzTvZMvwD

Top 5 Lifetime News Headlines

Top Authors

• Anamika Varghese
• Archana Sinha
• View all authors

Verification history

• 2,257 days ago


• View all verifications